Father Muller Medical College and Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2010
NCT01257906
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Father Muller Medical college,Kankanady,Mangalore

Active Ingredients

Drugs in Other Trials (2)

clindamycin (cleocin) (1 trial)

tretinoin (Retin-A) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2